Dr. M. Vanneste
ActiveSummary
Dr. M. Vanneste has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €93k and a net result of €155k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 35% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
82
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency70▼-30
Growth58▲+6
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.46 against 6.24 in 2024; short-term debt: 55.2% and cash: 66% of total assets), and 55.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
44.8%
Return on assets
75%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
23 d early
2024
29 d early
2023
37 d early
2022
2 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€93k▼ 72.2%
2024 · €332k
2022: €113k
2023: €225k
2024: €332k
2022 → 2025
Total assets
€207k▼ 46.4%
2024 · €386k
2022: €148k
2023: €250k
2024: €386k
2022 → 2025
Net result
€155k▲ 44.5%
2024 · €107k
2022: €110k
2023: €112k
2024: €107k
2022 → 2025
Working capital
€52k▼ 81.3%
2024 · €278k
2022: €111k
2023: €167k
2024: €278k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€113k-€225k▲ 99.3%€332k▲ 47.7%€93k▼ 72.2%
Operating result€142k-€144k▲ 1.4%€134k▼ 6.7%€195k▲ 45.1%
Net result€110k-€112k▲ 1.6%€107k▼ 4.3%€155k▲ 44.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 45% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €207k
Fixed assets
€40k ▼ 25.7%
Current assets
€166k ▼ 49.8%
Equity and liabilities €207k
Equity
€93k ▼ 72.2%
Debt
€114k ▲ 115%
Debt's share of the balance-sheet total rises from 13.8% to 55.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€209k▲
2024 · €147k
Cash flow
€169k▲
2024 · €120k
Current ratio
1.46▼
2024 · 6.24
Debt to equity
1.23▲
2024 · 0.16
ROE
167.5%▲
2024 · 32.3%
ROA
75.0%▲
2024 · 27.9%
Interest coverage
2782.51▲
2024 · 1868.88
Debt ≤ 1 year
€114k▲
2024 · €53k
Income taxes
€45k▲
2024 · €30k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet
Code20242025
Assets
Total assets20/58€386k€207k▼
Fixed assets21/28€54k€40k▼
Tangible fixed assets22/27€54k€40k▼
Furniture and vehicles24€54k€40k▼
Current assets29/58€331k€166k▼
Current investments50/53€216k€28k▼
Cash at bank and in hand54/58€115k€136k▲
Deferred charges and accrued income490/1€306€2k▲
Equity and liabilities
Total equity and liabilities10/49€386k€207k▼
Equity10/15€332k€93k▼
Contributions10/11€3k€3k=
Reserves13€330k€90k▼
Tax-exempt reserves132€42k€84k▲
Distributable reserves133€288k€6k▼
Amounts payable17/49€53k€114k▲
Amounts payable within one year42/48€53k€114k▲
Trade debts44€869-
Suppliers440/4€869-
Taxes, remuneration and social security45€50k€18k▼
Taxes450/3€50k€18k▼
Other amounts payable47/48€2k€96k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€14k▲
Other operating charges640/8€687€293▼
Gross operating margin9900€147k€209k▲
Operating profit (loss)9901€134k€195k▲
Financial income75/76B€3k€6k▲
Recurring financial income75€3k€6k▲
Financial charges65/66B€79€75▼
Recurring financial charges65€79€75▼
Profit (loss) for the period before taxes9903€137k€201k▲
Income taxes67/77€30k€45k▲
Profit (loss) for the period9904€107k€155k▲
Transfer to tax-exempt reserves689-€42k
Profit (loss) for the period to be appropriated9905€107k€113k▲
Appropriation of the result
Profit (loss) to be appropriated9906€107k€113k▲
Transfer from equity791/2-€285k
Transfer to equity691/2€107k€3k▼
To other reserves6921€107k€3k▼
Profit to be distributed694/7-€395k
Return on contributions (dividend)694-€395k
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
08-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2022net €155k ▲44.5%
Operating result €195k, net result €155k, both a record.
02-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €107k ▼4.3%
Net result drops to €107k, the lowest in the series; recovery starts the following year.
24-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €200kEq €225k ▲99.3%
2 profitable years in a row build equity to €225k.
02-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 2 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Waregem · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sioendreef 168791 WaregemGround area
1,062 m²
Building footprint
215 m²
Volume, LiDAR
1,454 m³
2 parcels, Flanders · tallest building 11.8 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Dr. M. Vanneste
since 20222.328.715.523
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34006A0392/00H000 | Flanders | 866 m² | 1 · 124 m² | 9.9 m · 2 fl. |
| 31808M0438/00R010 | Flanders | 196 m² | 1 · 90 m² | 11.8 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Cabinet de dermatologie Christian Defresne
BE 0508.715.708
Namur · Eq €92,561
PHILIPPE CREYF
BE 0890.784.850
Lasne · Eq €92,592
NODERMA
BE 1017.545.737
Walcourt · Eq €92,635
SCSPRL DOCTEUR LAETITIA BRASSINNE
BE 0644.629.138
Brussel · Eq €92,709
XHAËT NATHALIE
BE 0819.585.167
Nivelles · Eq €92,750
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,186 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded07-03-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.